SEARCH

SEARCH BY CITATION

References

  • Bolden, J.E., Peart, M.J. & Johnstone, R.W. (2006) Anticancer activities of histone deacetylase inhibitors. Nature Reviews Drug Discovery, 5, 769784.
  • Bradbury, C.A., Khanim, F.L., Hayden, R., Bunce, C.M., White, D.A., Drayson, M.T., Craddock, C. & Turner, B.M. (2005) Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia, 19, 17511759.
  • Chen, J., Odenike, O. & Rowley, J.D. (2010) Leukaemogenesis: more than mutant genes. Nature Reviews Cancer, 10, 2336.
  • Fraga, M.F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., Iyer, N.G., Perez-Rosado, A., Calvo, E., Lopez, J.A., Cano, A., Calasanz, M.J., Colomer, D., Piris, M.A., Ahn, N., Imhof, A., Caldas, C., Jenuwein, T. & Esteller, M. (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nature Genetics, 37, 391400.
  • Moreno, D.A., Scrideli, C.A., Cortez, M.A., de Paula Queiroz, R., Valera, E.T., da Silva Silveira, V., Yunes, J.A., Brandalise, S.R. & Tone, L.G. (2010) Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 150, 665673.
  • Morin, R.D., Mendez-Lago, M., Mungall, A.J., Goya, R., Mungall, K.L., Corbett, R.D., Johnson, N.A., Severson, T.M., Chiu, R., Field, M., Jackman, S., Krzywinski, M., Scott, D.W., Trinh, D.L., Tamura-Wells, J., Li, S., Firme, M.R., Rogic, S., Griffith, M., Chan, S., Yakovenko, O., Meyer, I.M., Zhao, E.Y., Smailus, D., Moksa, M., Chittaranjan, S., Rimsza, L., Brooks-Wilson, A., Spinelli, J.J., Ben Neriah, S., Meissner, B., Woolcock, B., Boyle, M., McDonald, H., Tam, A., Zhao, Y., Delaney, A., Zeng, T., Tse, K., Butterfield, Y., Birol, I., Holt, R., Schein, J., Horsman, D.E., Moore, R., Jones, S.J., Connors, J.M., Hirst, M., Gascoyne, R.D. & Marra, M.A. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature, 476, 298303.
  • Mullighan, C.G., Zhang, J., Kasper, L.H., Lerach, S., Payne-Turner, D., Phillips, L.A., Heatley, S.L., Holmfeldt, L., Collins-Underwood, J.R., Ma, J., Buetow, K.H., Pui, C.H., Baker, S.D., Brindle, P.K. & Downing, J.R. (2011) CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature, 471, 235239.
  • Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L.H., Lerach, S., Tang, H., Ma, J., Rossi, D., Chadburn, A., Murty, V.V., Mullighan, C.G., Gaidano, G., Rabadan, R., Brindle, P.K. & Dalla-Favera, R. (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature, 471, 189195.
  • Wang, J.C., Kafeel, M.I., Avezbakiyev, B., Chen, C., Sun, Y., Rathnasabapathy, C., Kalavar, M., He, Z., Burton, J. & Lichter, S. (2012) Histone deacetylase in chronic lymphocytic leukemia. Oncology, 81, 325329.
  • Wellen, K.E., Hatzivassiliou, G., Sachdeva, U.M., Bui, T.V., Cross, J.R. & Thompson, C.B. (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science, 324, 10761080.